Table of Contents Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs 1.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview 1.1.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Type 1.3.1 Macular Degeneration Drugs 1.3.2 Diabetic Retinopathy Drugs 1.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by End Users/Application 1.4.1 50-60 Years Old 1.4.2 60-70 Years Old 1.4.3 Other 2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Competition Analysis by Players 2.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Novartis 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Bayer Healthcare 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Roche 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Neurotech Pharmaceuticals 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Regeneron Pharmaceuticals 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Allergan 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.6.5 Recent Developments 4 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type and Application (2014-2019) 4.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type (2014-2019) 4.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 4.3 Potential Application of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Future 4.4 Top Consumer/End Users of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs 5 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 5.1 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 5.2 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 6 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 6.1 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 6.2 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 7 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 7.1 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 7.2 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 8.1 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 8.2 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 9.1 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 9.2 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 10.1 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 10.2 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Value) by Regions (2019-2025) 11.1.1 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.2 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.3 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Value) by Type (2019-2025) 11.3 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2019-2025) 12 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Dynamics 12.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Opportunities 12.2 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Scope Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) (2014-2019) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Regions in 2018 Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2018 Figure Macular Degeneration Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Diabetic Retinopathy Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2018 Table Key Downstream Customer in 50-60 Years Old Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in 50-60 Years Old (2014-2019) Table Key Downstream Customer in 60-70 Years Old Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in 60-70 Years Old (2014-2019) Table Key Downstream Customer in Other Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in Other (2014-2019) Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2018 and 2019) Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Table Novartis Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Novartis (2014-2019) Figure Novartis Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Bayer Healthcare Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Bayer Healthcare (2014-2019) Figure Bayer Healthcare Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Roche Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Roche (2014-2019) Figure Roche Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Neurotech Pharmaceuticals Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Neurotech Pharmaceuticals (2014-2019) Figure Neurotech Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Regeneron Pharmaceuticals Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Regeneron Pharmaceuticals (2014-2019) Figure Regeneron Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Allergan Basic Information List Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD) of Allergan (2014-2019) Figure Allergan Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Market Share in 2018 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Type (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2014 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2015 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2016 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2017 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2018 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2019 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2014 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2015 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2015 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2017 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2018 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2019 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Regions (2019-2025) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Regions (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Regions in 2019 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Regions in 2025 Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Type (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2019 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Type in 2025 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2019 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) by Application in 2025

Novartis Bayer Healthcare Roche Neurotech Pharmaceuticals Regeneron Pharmaceuticals Allergan